Company Filing History:
Years Active: 1993-1994
Title: Barry Stevens: Innovator in Intraocular Lens Technology
Introduction
Barry Stevens is a notable inventor based in Arlington, TX (US), recognized for his contributions to the field of ophthalmic devices. He holds 2 patents that showcase his innovative approach to intraocular lens technology.
Latest Patents
One of Stevens' latest patents is the Intraocular Lens Folder. This device features a generally planar, open frame shaped like a rounded 'A,' with a rimmed, open head at the top. The base of the 'A' forms a pair of opposing legs or handles that connect at a hinge, allowing the handles to be squeezed together and spring apart when released. This mechanism enables the top edge of the head rim to compress, facilitating the folding of the intraocular lens (IOL) into the open head, which contains projections that help in the folding process.
Another significant patent is for Bicomposite Intraocular Lenses. This invention involves hydrogel intraocular lenses that have one or more haptic portions with a lower water content than the corresponding optic portions. The manufacturing process includes preparing a bicomposite button of hydrogel material, lathing it to create a dehydrated lens, and then hydrating the lens to achieve the desired properties.
Career Highlights
Throughout his career, Barry Stevens has worked with prominent companies in the ophthalmic industry, including Alcon Laboratories, Inc. and Alcon Surgical, Inc. His experience in these organizations has contributed to his expertise in developing advanced intraocular lens technologies.
Collaborations
Stevens has collaborated with notable professionals in the field, including Graham D. Barrett and Stephen J. Van Noy. These collaborations have likely enriched his work and contributed to the success of his inventions.
Conclusion
Barry Stevens is a distinguished inventor whose work in intraocular lens technology has made a significant impact in the field. His innovative patents and collaborations reflect his commitment to advancing ophthalmic solutions.